找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Drug Discovery and Development; From Targets and Mol Ramarao Poduri Book 2021 Springer Nature Singapore Pte Ltd. 2021 Drug discovery.Pharma

[復制鏈接]
樓主: Covenant
31#
發(fā)表于 2025-3-27 00:32:49 | 只看該作者
32#
發(fā)表于 2025-3-27 01:43:07 | 只看該作者
https://doi.org/10.1007/978-3-7091-8827-9n research and development of stem cells, selecting the source for stem cells, various feasible applications of stem cells, pharmacological bridging with stem cells, preclinical safety evaluation of stem cells, and finally a section on potential applications of stem cells in future.
33#
發(fā)表于 2025-3-27 05:49:49 | 只看該作者
Negative und komplexe Zahlen, Polynome,horough knowledge of the toxicological potential of nanocarriers. Further, the harmonious integration of academia, researcher, industries and regulatory bodies is warranted to ensure the proper regulation of their use.
34#
發(fā)表于 2025-3-27 10:29:33 | 只看該作者
Genetics and Drug Discovery,iew about the mechanisms involved and aim for new drug candidates. Here in this chapter, we discuss the overview of the basic principles involved in genetics, genetic mutations, and related methods engaged in drug discovery.
35#
發(fā)表于 2025-3-27 15:56:09 | 只看該作者
Discovery and Development of Stem Cells for Therapeutic Applications,n research and development of stem cells, selecting the source for stem cells, various feasible applications of stem cells, pharmacological bridging with stem cells, preclinical safety evaluation of stem cells, and finally a section on potential applications of stem cells in future.
36#
發(fā)表于 2025-3-27 20:16:37 | 只看該作者
37#
發(fā)表于 2025-3-27 21:58:16 | 只看該作者
38#
發(fā)表于 2025-3-28 04:00:29 | 只看該作者
39#
發(fā)表于 2025-3-28 06:32:21 | 只看該作者
Clinical Research in Pharmaceutical Drug Development,g proper endpoints, selecting correct study designs, securing quality data, and statistical analyses..As clinical research encompasses a large?part of?drug development, it is difficult to cover?the subject in detail in one chapter; hence we are providing a high-level?overview.
40#
發(fā)表于 2025-3-28 12:49:55 | 只看該作者
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學 Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點評 投稿經(jīng)驗總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學 Yale Uni. Stanford Uni.
QQ|Archiver|手機版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-14 23:16
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復 返回頂部 返回列表
青海省| 同德县| 威远县| 芷江| 酒泉市| 武冈市| 崇仁县| 白银市| 吐鲁番市| 安多县| 隆化县| 梁河县| 米易县| 吉林市| 垣曲县| 新巴尔虎左旗| 兰西县| 宁海县| 南京市| 浦北县| 长武县| 淮滨县| 石柱| 临猗县| 乌审旗| 琼中| 岑溪市| 临清市| 庄浪县| 武乡县| 绥江县| 云安县| 嘉禾县| 尚志市| 舒兰市| 米脂县| 玛纳斯县| 拉萨市| 将乐县| 三穗县| 南涧|